The Mix Tape | Special Edition – Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval
In part 2 of our Special Edition Series – Cell and Gene Tx Journey to Commercialization – Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences leading commercial teams, including advice on how best to prepare for commercialization.